[DKG Certification of Paediatric Cancer Centres - A wide Field …]

Overview

Journal Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz

Publisher Springer

Specialty Public Health

Date 2020 Mar 13

PMID 32161982

Citations 2

Authors

Melchior Lauten

Udo Kontny

Michaela Nathrath

Martin Schrappe

Affiliations

Soon will be listed here.

Abstract

The German Society of Paediatric Oncology and Haematology (GPOH) and the German Cancer Society (DKG) have defined criteria for DKG certification of paediatric oncology departments. Since 2017, several paediatric oncology departments have already been certified according to these criteria. DKG certification aims for the harmonized and transparent presentation of the quality of care of paediatric oncology patients, as described by Mensah et al. The definition of certification criteria led to controversies within the GPOH about how far the criteria themselves would withstand scientific verifiability.We critically reviewed the paper by Mensah et al. asking whether valid conclusions for the German health system could be drawn from it. We found that currently defined criteria for DKG certification of paediatric oncology departments lack scientific evidence for German paediatric cancer centres in critical aspects.This article challenges case numbers as a parameter for the measurement of quality of care in German paediatric oncology. We try to contribute to an open discussion about alternative criteria for ensuring quality of care in German paediatric oncology departments.

Citing Articles

Quality criteria and certification for paediatric oncology centres: an international cross-sectional survey.

Schladerer S, Otth M, Scheinemann K Int J Qual Health Care. 2024; 36(3).

PMID: 39120965 PMC: 11363956. DOI: 10.1093/intqhc/mzae079.

Quality criteria for pediatric oncology centers: A systematic literature review.

Schladerer S, Otth M, Scheinemann K Cancer Med. 2023; 12(18):18999-19012.

PMID: 37584279 PMC: 10557895. DOI: 10.1002/cam4.6452.

References

Kowalczyk J, Samardakiewicz M, Fitzgerald E, Essiaf S, Ladenstein R, Vassal G . Towards reducing inequalities: European Standards of Care for Children with Cancer. Eur J Cancer. 2013; 50(3):481-5. DOI: 10.1016/j.ejca.2013.11.004. View

Gutierrez J, Cheung M, Zhuge Y, Koniaris L, Sola J . Does Children's Oncology Group hospital membership improve survival for patients with neuroblastoma or Wilms tumor?. Pediatr Blood Cancer. 2010; 55(4):621-8. DOI: 10.1002/pbc.22631. View

Gatta G, Botta L, Comber H, Dimitrova N, Leinonen M, Pritchard-Jones K . The European study on centralisation of childhood cancer treatment. Eur J Cancer. 2019; 115:120-127. DOI: 10.1016/j.ejca.2019.04.024. View

Stiller C, Benjamin S, Cartwright R, Clough J, Gorst D, Kroll M . Patterns of care and survival for adolescents and young adults with acute leukaemia--a population-based study. Br J Cancer. 1999; 79(3-4):658-65. PMC: 2362441. DOI: 10.1038/sj.bjc.6690104. View

Stiller C . Centralised treatment, entry to trials and survival. Br J Cancer. 1994; 70(2):352-62. PMC: 2033490. DOI: 10.1038/bjc.1994.306. View

Stiller C . Centralisation of treatment and survival rates for cancer. Arch Dis Child. 1988; 63(1):23-30. PMC: 1779345. DOI: 10.1136/adc.63.1.23. View

Fuchs J, Kienecker K, Furtwangler R, Warmann S, Burger D, Thurhoff J . Surgical aspects in the treatment of patients with unilateral wilms tumor: a report from the SIOP 93-01/German Society of Pediatric Oncology and Hematology. Ann Surg. 2009; 249(4):666-71. DOI: 10.1097/SLA.0b013e31819ed92b. View

Truong T, Pole J, Barber R, Dix D, Kulkarni K, Martineau E . Enrollment on clinical trials does not improve survival for children with acute myeloid leukemia: A population-based study. Cancer. 2018; 124(20):4098-4106. DOI: 10.1002/cncr.31728. View

Strahlendorf C, Pole J, Barber R, Dix D, Kulkarni K, Martineau E . Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study. Br J Cancer. 2018; 118(5):744-749. PMC: 5846068. DOI: 10.1038/bjc.2017.462. View

10.

Halperin E, Laurie F, Fitzgerald T . An evaluation of the relationship between the quality of prophylactic cranial radiotherapy in childhood acute leukemia and institutional experience: a Quality Assurance Review Center-Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys. 2002; 53(4):1001-4. DOI: 10.1016/s0360-3016(02)02833-x. View

11.

Knops R, van Dalen E, Mulder R, Leclercq E, Knijnenburg S, Kaspers G . The volume effect in paediatric oncology: a systematic review. Ann Oncol. 2013; 24(7):1749-1753. DOI: 10.1093/annonc/mds656. View

12.

Smith E, Butler W, Barker 2nd F . Craniotomy for resection of pediatric brain tumors in the United States, 1988 to 2000: effects of provider caseloads and progressive centralization and specialization of care. Neurosurgery. 2004; 54(3):553-63. DOI: 10.1227/01.neu.0000108421.69822.67. View

13.

Salstrom J, Coughlin R, Pool K, Bojan M, Mediavilla C, Schwent W . Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs. Pediatr Blood Cancer. 2015; 62(5):807-15. PMC: 4413050. DOI: 10.1002/pbc.25435. View

14.

Mensah J, Jurgens H, Eggert A, Wesselmann S . [DKG Certification of Paediatric Cancer Centres]. Klin Padiatr. 2018; 230(6):314-318. DOI: 10.1055/a-0633-3187. View

15.

Stiller C, Eatock E . Survival from acute non-lymphocytic leukaemia, 1971-88: a population based study. Arch Dis Child. 1994; 70(3):219-23. PMC: 1029747. DOI: 10.1136/adc.70.3.219. View

16.

Horowitz M, Przepiorka D, Champlin R, Gale R, Gratwohl A, Herzig R . Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers?. Blood. 1992; 79(10):2771-4. View

17.

Stiller C, Eatock E . Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994. Arch Dis Child. 1999; 81(3):202-8. PMC: 1718071. DOI: 10.1136/adc.81.3.202. View

18.

Craft A, Amineddine H, Scott J, Wagget J . The Northern region Children's malignant disease registry 1968-82: incidence and survival. Br J Cancer. 1987; 56(6):853-8. PMC: 2002394. DOI: 10.1038/bjc.1987.305. View

19.

Stiller C, Draper G . Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia. Arch Dis Child. 1989; 64(5):657-61. PMC: 1792031. DOI: 10.1136/adc.64.5.657. View

20.

Fern L, Davies S, Eden T, Feltbower R, Grant R, Hawkins M . Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group. Br J Cancer. 2008; 99(12):1967-74. PMC: 2607227. DOI: 10.1038/sj.bjc.6604751. View